70.92
price down icon2.92%   -2.13
after-market Handel nachbörslich: 70.92
loading
Schlusskurs vom Vortag:
$73.05
Offen:
$71.35
24-Stunden-Volumen:
911.82K
Relative Volume:
1.86
Marktkapitalisierung:
$5.27B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-224.29M
KGV:
-18.18
EPS:
-3.9
Netto-Cashflow:
$-185.06M
1W Leistung:
-8.06%
1M Leistung:
-5.41%
6M Leistung:
-30.67%
1J Leistung:
-5.55%
1-Tages-Spanne:
Value
$67.47
$72.85
1-Wochen-Bereich:
Value
$67.47
$77.92
52-Wochen-Spanne:
Value
$61.80
$113.51

Nuvalent Inc Stock (NUVL) Company Profile

Name
Firmenname
Nuvalent Inc
Name
Telefon
508-446-2272
Name
Adresse
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
NUVL's Discussions on Twitter

Vergleichen Sie NUVL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NUVL
Nuvalent Inc
70.92 5.27B 0 -224.29M -185.06M -3.90
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Nuvalent Inc Stock (NUVL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-14 Hochstufung UBS Neutral → Buy
2024-12-30 Eingeleitet H.C. Wainwright Buy
2024-10-24 Eingeleitet UBS Neutral
2024-08-29 Eingeleitet Barclays Overweight
2024-04-17 Eingeleitet Jefferies Buy
2024-04-01 Hochstufung Leerink Partners Market Perform → Outperform
2024-02-28 Fortgesetzt Guggenheim Buy
2024-02-23 Eingeleitet Robert W. Baird Outperform
2023-09-27 Eingeleitet Stifel Buy
2023-08-08 Eingeleitet SVB Securities Market Perform
2023-07-24 Eingeleitet Guggenheim Buy
2023-01-18 Eingeleitet Wedbush Outperform
2022-06-24 Eingeleitet BMO Capital Markets Outperform
Alle ansehen

Nuvalent Inc Aktie (NUVL) Neueste Nachrichten

pulisher
Mar 30, 2025

Teacher Retirement System of Texas Boosts Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Why Nuvalent (NUVL) Is Among the Best Mid Cap Biotech Stocks to Buy - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

Nuvalent chief development officer sells shares worth $292,468 By Investing.com - Investing.com Philippines

Mar 29, 2025
pulisher
Mar 28, 2025

Nuvalent chief development officer sells shares worth $292,468 - Investing.com India

Mar 28, 2025
pulisher
Mar 26, 2025

10 Best Mid Cap Biotech Stocks to Buy - Insider Monkey

Mar 26, 2025
pulisher
Mar 25, 2025

Breakthrough Cancer Drug Data: New Brain-Penetrant Therapy Shows Promise Against Resistant Tumors - Stock Titan

Mar 25, 2025
pulisher
Mar 22, 2025

How the (NUVL) price action is used to our Advantage - news.stocktradersdaily.com

Mar 22, 2025
pulisher
Mar 21, 2025

Raymond James Financial Inc. Acquires Shares of 133,964 Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

Nuvalent CEO Porter sells $2.05 million in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Nuvalent CEO Porter sells $2.05 million in stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Victory Capital Management Inc. Cuts Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

Charles Schwab Investment Management Inc. Buys 7,742 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

US Bancorp DE Invests $90,000 in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

Bank of New York Mellon Corp Increases Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

UBS Upgrades Nuvalent (NUVL) - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Nuvalent upgraded to Buy from Neutral at UBS - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

UBS Upgrades Nuvalent to Buy From Neutral, Maintains $100 Price Target -March 14, 2025 at 07:24 am EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 08, 2025

Principal Financial Group Inc. Cuts Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

HC Wainwright Has Negative Forecast for Nuvalent Q1 Earnings - Defense World

Mar 06, 2025
pulisher
Mar 04, 2025

Nuvalent’s (NUVL) Buy Rating Reaffirmed at HC Wainwright - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

H.C. Wainwright maintains Buy on Nuvalent stock, $110 target By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

New York State Common Retirement Fund Sells 2,495 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Where are the Opportunities in (NUVL) - news.stocktradersdaily.com

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Has $3.95 Million Stake in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Nuvalent’s Strategic Advances in NSCLC Trials Justify Buy Rating - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Nuvalent to Participate in Upcoming March Investor Conferences - Citizentribune

Feb 28, 2025
pulisher
Feb 28, 2025

Nuvalent, Inc. Reports 2024 Financial Results and Pipeline Progress - TipRanks

Feb 28, 2025
pulisher
Feb 27, 2025

Nuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve

Feb 27, 2025
pulisher
Feb 27, 2025

Nuvalent's Q4 Net Loss Widens -February 27, 2025 at 07:14 am EST - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings Flash (NUVL) Nuvalent Posts Q4 Net Loss $1.05 a Share, vs. FactSet Est of $1.08 Loss - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Nuvalent, Inc. SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 26, 2025

Nuvalent director Shair sells $156,863 in class A common stock By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 26, 2025

State of New Jersey Common Pension Fund D Has $1.81 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Feb 26, 2025
pulisher
Feb 26, 2025

Nuvalent director Shair sells $156,863 in class A common stock - Investing.com India

Feb 26, 2025
pulisher
Feb 24, 2025

Can This Biotech Executive's $6.3B Deal Experience Transform Climb Bio's Future? - Stock Titan

Feb 24, 2025
pulisher
Feb 23, 2025

Nuvalent (NUVL) Projected to Post Earnings on Tuesday - Defense World

Feb 23, 2025
pulisher
Feb 21, 2025

Nuvalent CEO sells stock worth over $2.1 million By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Nuvalent CEO sells stock worth over $2.1 million - Investing.com India

Feb 21, 2025
pulisher
Feb 18, 2025

(NUVL) Proactive Strategies - Stock Traders Daily

Feb 18, 2025
pulisher
Feb 18, 2025

Nuvalent (NUVL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Feb 18, 2025
pulisher
Feb 14, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus Target Price from Analysts - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

Q1 Earnings Estimate for Nuvalent Issued By Leerink Partnrs - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

abrdn plc Buys 9,241 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus PT from Brokerages - Defense World

Feb 13, 2025
pulisher
Feb 11, 2025

10 Mid-Cap Stocks Insiders Are Selling Recently - Insider Monkey

Feb 11, 2025
pulisher
Feb 11, 2025

Why Insiders Are Selling Nuvalent, Inc. (NUVL) Recently - Insider Monkey

Feb 11, 2025
pulisher
Feb 08, 2025

KBC Group NV Boosts Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Feb 08, 2025

Finanzdaten der Nuvalent Inc-Aktie (NUVL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Kapitalisierung:     |  Volumen (24h):